The SARS-CoV-2 pandemic has created an enormous challenge for laboratories and communities worldwide. Currently, laboratories require cost-effective and rapid solutions to track the key SARS-CoV-2 variants currently in circulation, globally. While sequencing-based technologies are commonly used, they are highly complex, expensive, and have a long turnaround time.
To meet these challenges, Agena Bioscience® has developed the MassARRAY® SARS-CoV-2 Variant Panel (RUO), the MassARRAY SARS-CoV-2 Panel (EUA, CE-IVD), and the MassARRAY SARS-CoV-2/Flu Panel (RUO). These panels enable accurate, high-throughput, and low-cost detection of SARS-CoV-2, dominant SARS-CoV-2 variants, and influenza RNA.